Health insurers slammed after UnitedHealth says more surgeries driving up costs
Reuters
Published Jun 14, 2023 10:06AM ET
Updated Jun 14, 2023 05:36PM ET
By Bhanvi Satija and Leroy Leo
(Reuters) -Health insurer stocks dropped sharply on Wednesday after UnitedHealth Group (NYSE:UNH) said its costs were on the rise due to an increase in surgeries among older adults.
Shares of UnitedHealth, the largest U.S. healthcare provider by market value, closed down 6.4% at $459.86, wiping out roughly $29 billion from the industry bellwether's market capitalization.
Medicare-focused insurer Humana Inc (NYSE:HUM) closed about 11% down, and a broader index of managed care providers closed 6.9% lower.
Insurers have been benefiting from a delay in non-urgent surgeries due to the COVID-19 pandemic and hospital staffing shortages, but UnitedHealth's comments show that the gains may be waning.
Meanwhile, stocks of medical device makers and hospital operators rose, as increased frequency of surgeries mean more revenue for them.
Older adults aged 65 and above covered under Medicare, who had largely stayed indoors during a large part of the pandemic, are getting "more comfortable accessing services for things that they might have pushed off a bit like knees and hips," UnitedHealth executives said.
The company highlighted strong demand for hip and knee procedures at outpatient centers, as well as for home health services and behavioral services.
Insurer Elevance Health, CVS Health Corp (NYSE:CVS), Centene (NYSE:CNC) Corp and Cigna (NYSE:CI) Group closed between 3% and 8% lower.
UnitedHealth's warning was, however, in sharp contrast to commentary from other insurers, including Elevance, which said on Monday that medical care trends were in line with expectations.
Elevance executives had said they did not expect a surge in demand due to people making up for delayed procedures.
UnitedHealth said it expects second-quarter medical loss ratio - a percentage of spend on claims compared to premiums collected - to rise to the high end, or moderately above its full-year outlook of 82.1% to 83.1%, due to pent-up demand for surgeries.
The company's 18.51 forward 12-month price-to-earnings ratio, a common benchmark for valuing stocks, is higher than rival Cigna's 10.29 and CVS Health's 8.26.
Get The News You Want
"A lot of this (increase in demand) is being driven by physician offices opening up and increasing capacity," Jefferies analyst Brian Tanquilut said, adding that he expects the pent-up demand to act as a tailwind for hospitals at least for the next two quarters.
Shares of hospital operators HCA Healthcare (NYSE:HCA) and Tenet Healthcare (NYSE:THC) closed up between 1.5% and 2.5%, while implant and joint replacement product makers Stryker Corp (NYSE:SYK) and Zimmer Biomet closed about 4% higher.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.